Leukocyte immunoglobulin-like receptors (LIRs) are members of the immunoglobulin superfamily of glycoproteins and are predominantly expressed by monocytes, B cells, dendritic cells, natural killer (NK) cells, peripheral blood leukocytes and tissues such as placenta, lung and liver. Immunoglobulin-like transcript 2 (ILT-2), also known as CD85 or MIR7, is a 650 amino acid glycoprotein that contains a 23 amino acid signal peptide, 4 extracellular C2-type IGSF domains and 4 intracellular ITIM motifs. ILT-2 can bind major histocompatability (MHC) class I molecules and inhibit cell termination by natural killer (NK) and T cells, and inhibit Ca2+ mobilization in myeloid cells triggered through the B cell antigen receptor and histocompatibility leukocyte antigens (HLA)-DR. ILT-2 contains four putative cytoplasmic tyrosine-based inhibitory motifs and upon tyrosine phosphorylation, associates with the tyrosine phosphatase SHP-1.
Formulation
1 mg/ml in 1X PBS; BSA free, sodium azide free
Host
Mouse
Immunogen Region
Hairy cell leukemia cells were used as the immunogen for the LILRB1 antibody.
Isotype
Mouse IgG1, kappa
Species Reactivity
Human
Note
Optimal dilution of the LILRB1 antibody should be determined by the researcher.
Uniprot
Q8NHL6
Format
Purified
Purity
Protein G affinity chromatography
Storage
Store the LILRB1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Applications
IP, WB, FACS
Description
Immunoprecipitation: 1-2ug per 100-500ug of total protein (1ml of cell lysate),Weste blot: 1-2ug/ml,Flow cytometry: 1-2ug/million cells